Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis
Małgorzata Milkiewicz, Marta Klak, Agnieszka Kempińska‐Podhorodecka, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Targeting the FGF19–FGFR4 pathway for cholestatic, metabolic, and cancerous diseases
Xiaokun Li, Weiqin Lu, Alexei Kharitonenkov, et al.
Journal of Internal Medicine (2024) Vol. 295, Iss. 3, pp. 292-312
Open Access | Times Cited: 24
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
Gideon M. Hirschfield, Olivier Chazouillères, Joost P.H. Drenth, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 3, pp. 483-493
Open Access | Times Cited: 152
Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives
Emmanuel Somm, François R. Jornayvaz
Endocrine Reviews (2018) Vol. 39, Iss. 6, pp. 960-989
Open Access | Times Cited: 94
Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis
Benedikt Simbrunner, Michael Trauner, Thomas Reiberger
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 10, pp. 1243-1262
Open Access | Times Cited: 70
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis
You Sun Kim, Edward Hurley, Yoojeong Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1380-1387
Open Access | Times Cited: 29
Comparison of intestinal expression of the apical sodium‐dependent bile acid transporter between dogs with and without chronic inflammatory enteropathy
Paula R. Giaretta, Raquel R. Rech, Blake C. Guard, et al.
Journal of Veterinary Internal Medicine (2018) Vol. 32, Iss. 6, pp. 1918-1926
Open Access | Times Cited: 70
Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities
Mette Vesterhus, Tom H. Karlsen
Journal of Gastroenterology (2020) Vol. 55, Iss. 6, pp. 588-614
Open Access | Times Cited: 64
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
Ji Won Park, Jung Hee Kim, Sung Eun Kim, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1288-1288
Open Access | Times Cited: 33
Fibroblast growth factor 15/19 expression, regulation, and function: An overview
Gregory Guthrie, Caitlin Vonderohe, Douglas G. Burrin
Molecular and Cellular Endocrinology (2022) Vol. 548, pp. 111617-111617
Open Access | Times Cited: 29
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review
Teresa Da Cunha, Haleh Vaziri, George Y. Wu
Journal of Clinical and Translational Hepatology (2022) Vol. 10, Iss. 3, pp. 531-542
Open Access | Times Cited: 28
FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence
Benedikt Simbrunner, Benedikt Hofer, Philipp Schwabl, et al.
Hepatology International (2024) Vol. 18, Iss. 3, pp. 929-942
Open Access | Times Cited: 6
Primary sclerosing cholangitis
Anahita Rabiee, Marina G. Silveira
Translational Gastroenterology and Hepatology (2020) Vol. 6, pp. 29-29
Open Access | Times Cited: 41
Navigating the gut-liver axis: the potential of tea to alleviate inflammatory bowel disease and associated metabolic syndromes
Qi Fang, Chunyin Qin, Ying Peng, et al.
Trends in Food Science & Technology (2025), pp. 104893-104893
Closed Access
Management of primary sclerosing cholangitis and its complications: an algorithmic approach
Michal Prokopič, Ulrich Beuers
Hepatology International (2020) Vol. 15, Iss. 1, pp. 6-20
Open Access | Times Cited: 36
The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2959-2959
Open Access | Times Cited: 30
Altered Bioavailability and Pharmacokinetics in Crohn’s Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs
Sarah Alrubia, Jialin Mao, Yuan Chen, et al.
Clinical Pharmacokinetics (2022) Vol. 61, Iss. 10, pp. 1365-1392
Open Access | Times Cited: 19
The Impact of Human Liver Transplantation on the Concentration of Fibroblast Growth Factors: FGF19 and FGF21
Marta Budkowska, Ewa Ostrycharz, Elżbieta Cecerska‐Heryć, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1299-1299
Open Access
Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis
Pamela S. Tietz-Bogert, Minsuk Kim, Angela Cheung, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3188-3188
Open Access | Times Cited: 32
Bile Acids and Biliary Fibrosis
Sayed Obaidullah Aseem, Phillip B. Hylemon, Huiping Zhou
Cells (2023) Vol. 12, Iss. 5, pp. 792-792
Open Access | Times Cited: 10
Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis
Atsuto Kayashima, Tomohisa Sujino, Seiichiro Fukuhara, et al.
Hepatology Communications (2024) Vol. 8, Iss. 6
Open Access | Times Cited: 2
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments
Stefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1650-1650
Open Access | Times Cited: 2
Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition
Esther Verkade, Wenqiang Shen, Milaine V. Hovingh, et al.
Clinical Science (2023) Vol. 137, Iss. 21, pp. 1637-1650
Open Access | Times Cited: 6
MALDI Mass Spectral Imaging of Bile Acids Observed as Deprotonated Molecules and Proton-Bound Dimers from Mouse Liver Sections
Ignacy Rzagalinski, Nadine Hainz, Carola Meier, et al.
Journal of the American Society for Mass Spectrometry (2018) Vol. 29, Iss. 4, pp. 711-722
Open Access | Times Cited: 16
Expression of Bile Acid Receptors and Transporters Along the Intestine of Patients With Type 2 Diabetes and Controls
Henriette H Nerild, Hannah Gilliam-Vigh, Anne‐Marie Ellegaard, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 1
Precision medicine in primary sclerosing cholangitis
James Maurice, Douglas Thorburn
Journal of Digestive Diseases (2019) Vol. 20, Iss. 7, pp. 346-356
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top